[
  {
    "ts": null,
    "headline": "Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'",
    "summary": "Steris had a strong performance in the Applied Sterilization Technologies segment in Q2 FY25. See why STE stock's business lines are well-positioned for recovery.",
    "url": "https://finnhub.io/api/news?id=133603040ed3a99e175654d18a5ad850dfc9a8058b955038230af822a9789308",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731877112,
      "headline": "Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'",
      "id": 131434189,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1585552994/image_1585552994.jpg?io=getty-c-w1536",
      "related": "STE",
      "source": "SeekingAlpha",
      "summary": "Steris had a strong performance in the Applied Sterilization Technologies segment in Q2 FY25. See why STE stock's business lines are well-positioned for recovery.",
      "url": "https://finnhub.io/api/news?id=133603040ed3a99e175654d18a5ad850dfc9a8058b955038230af822a9789308"
    }
  }
]